Assembly Biosciences Files Q1 2025 10-Q
Ticker: ASMB · Form: 10-Q · Filed: May 8, 2025 · CIK: 1426800
| Field | Detail |
|---|---|
| Company | Assembly Biosciences, INC. (ASMB) |
| Form Type | 10-Q |
| Filed Date | May 8, 2025 |
| Risk Level | medium |
| Sentiment | neutral |
Sentiment: neutral
Topics: 10-Q, biotech, collaboration, financials
Related Tickers: GILD
TL;DR
ASMB Q1 25 10-Q filed. Cash, equity, Gilead deal updates.
AI Summary
Assembly Biosciences, Inc. filed its 10-Q for the period ending March 31, 2025. The company reported its financial results and provided updates on its business operations. Key details regarding cash, equity, and agreements with entities like Gilead Sciences Incorporated are included in the filing.
Why It Matters
This filing provides investors with the latest financial performance and operational updates for Assembly Biosciences, crucial for understanding the company's current standing and future prospects.
Risk Assessment
Risk Level: medium — Biotech companies often face inherent risks due to the nature of drug development and regulatory processes.
Key Numbers
- 2025-03-31 — Reporting Period End Date (Indicates the end of the financial quarter being reported.)
- 2025-05-08 — Filing Date (The date the 10-Q was officially submitted to the SEC.)
Key Players & Entities
- ASSEMBLY BIOSCIENCES, INC. (company) — Filer of the 10-Q
- Gilead Sciences Incorporated (company) — Partner in agreements
- 20250331 (date) — End of reporting period
- 20250508 (date) — Filing date
FAQ
What were Assembly Biosciences' key financial highlights for the quarter ending March 31, 2025?
The 10-Q filing for the period ending March 31, 2025, provides detailed financial statements, but specific dollar amounts for revenue, net income, or cash flow are not explicitly listed in the provided text snippet.
What is the nature of the agreements between Assembly Biosciences and Gilead Sciences Incorporated mentioned in the filing?
The filing mentions 'Equity Agreements' and 'Option License And Collaboration Agreement' between Assembly Biosciences and Gilead Sciences Incorporated, indicating a partnership or licensing arrangement.
When did Assembly Biosciences change its name from VENTRUS BIOSCIENCES INC?
Assembly Biosciences, Inc. changed its name from VENTRUS BIOSCIENCES INC on February 11, 2008.
What is the Standard Industrial Classification (SIC) code for Assembly Biosciences?
The SIC code for Assembly Biosciences is 2834, which corresponds to Pharmaceutical Preparations.
What is the fiscal year end for Assembly Biosciences?
Assembly Biosciences' fiscal year ends on December 31.
Filing Details
This Form 10-Q (Form 10-Q) was filed with the SEC on May 8, 2025 regarding ASSEMBLY BIOSCIENCES, INC. (ASMB).